MedPath

Combination of Remifentanil and Flurbiprofen in Sedation and Analgesia for ESWL of Pancreatic Stone

Phase 4
Completed
Conditions
Pancreatic Stone Disease
Interventions
Registration Number
NCT01998217
Lead Sponsor
Changhai Hospital
Brief Summary

Extracorporeal shock wave lithotripsy (ESWL) of pancreatic stones has been described as an effective approach for stone drainage and pain relief, and general or epidural anesthesia has been reported for such procedure. Single infusion of remifentanil has been described in ESWL of urinary stones, but it has never been described in ESWL of pancreatic stones. Moreover, single infusion of remifentanil might induce several complications, such as postoperative nausea and vomiting. The investigators attended to investigated whether combination of flurbiprofen with remifentanil reduced remifentanil dose and attenuated the complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • aged 18-65 years
  • ASA I-II
  • ESWL indication was met
Exclusion Criteria
  • patients with hypertension
  • patients compromised in cardiopulmonary function
  • patients undergoing ESWL for the second or more times

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Flur groupFlurbiprofen and remifentanilPatients in this group receive both infusion of flurbiprofen and remifentanil
Rem groupRemifentanilPatients in this group receive single infusion of remifentanil with target concentration infusion.
Primary Outcome Measures
NameTimeMethod
Visual analogue score of painDuring ESWL procedure
Secondary Outcome Measures
NameTimeMethod
Cardiovascular responses including blood pressure and heart rateDuring ESWL procedure

Trial Locations

Locations (1)

Department of Anesthesiology, Changhai Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath